3rd October 2022
From FLAIR to STATIC – what’s involved and what are the implications for CLL patients. This webinar with Tal Munir explores the impact of the switch from FLAIR to STATIC for patients, whether on the original FLAIR trial or not and how they can be involved. If you are taking ibrutinib, this will be of interest.
Who we are
We are a patient led UK charity, our mission is to support and empower CLL patients, their families and their carers.
Read moreOur 24 hour membership telephone number is: 0800 977 4396
About CLL
CLL is a malignancy of B lymphocytes, one of several types of cells of the immune system.
Read moreAbout CLL
Donate
Donate to support our CLL community
Donate nowHealthUnlocked
Connect to others who understand
Open in a new tabThis page was last reviewed 3rd November 2022. Next review November 2025
Send us feedback about this pageSend us feedback about this page
Help us to ensure we deliver the best content we can by giving us feedback about this page, good or bad. Please provide an email address if you would like us to respond to your feedback.
"*" indicates required fields
